Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2005-04-05

AUTHORS

D D Stocken, M W Büchler, C Dervenis, C Bassi, H Jeekel, J H G Klinkenbijl, K E Bakkevold, T Takada, H Amano, J P Neoptolemos

ABSTRACT

The aim of this study was to investigate the worldwide evidence of the roles of adjuvant chemoradiation and adjuvant chemotherapy on survival in potentially curative resected pancreatic cancer. Five randomised controlled trials of adjuvant treatment in patients with histologically proven pancreatic ductal adenocarcinoma were identified, of which the four most recent trials provided individual patient data (875 patients). This meta-analysis includes previously unpublished follow-up data on 261 patients. The pooled estimate of the hazard ratio (HR) indicated a 25% significant reduction in the risk of death with chemotherapy (HR=0.75, 95% confidence interval (CI): 0.64, 0.90, P-valuesstratified (Pstrat)=0.001) with median survival estimated at 19.0 (95% CI: 16.4, 21.1) months with chemotherapy and 13.5 (95% CI: 12.2, 15.8) without. The 2- and 5-year survival rates were estimated at 38 and 19%, respectively, with chemotherapy and 28 and 12% without. The pooled estimate of the HR indicated no significant difference in the risk of death with chemoradiation (HR=1.09, 95% CI: 0.89, 1.32, Pstrat=0.43) with median survivals estimated at 15.8 (95% CI: 13.9, 18.1) months with chemoradiation and 15.2 (95% CI: 13.1, 18.2) without. The 2- and 5-year survival rates were estimated at 30 and 12%, respectively, with chemoradiation and 34 and 17% without. Subgroup analyses estimated that chemoradiation was more effective and chemotherapy less effective in patients with positive resection margins. These results show that chemotherapy is effective adjuvant treatment in pancreatic cancer but not chemoradiation. Further studies with chemoradiation are warranted in patients with positive resection margins, as chemotherapy appeared relatively ineffective in this patient subgroup. More... »

PAGES

1372-1381

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6602513

DOI

http://dx.doi.org/10.1038/sj.bjc.6602513

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015676534

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15812554


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Pancreatic Ductal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK", 
          "id": "http://www.grid.ac/institutes/grid.470294.c", 
          "name": [
            "Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stocken", 
        "givenName": "D D", 
        "id": "sg:person.0750176774.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750176774.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Heidelberg, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7700.0", 
          "name": [
            "University of Heidelberg, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "B\u00fcchler", 
        "givenName": "M W", 
        "id": "sg:person.07610347412.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07610347412.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Agia Olga Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.413412.1", 
          "name": [
            "Agia Olga Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dervenis", 
        "givenName": "C", 
        "id": "sg:person.0733477707.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733477707.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Verona, Verona, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5611.3", 
          "name": [
            "University of Verona, Verona, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bassi", 
        "givenName": "C", 
        "id": "sg:person.01345167253.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345167253.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Rotterdam, Rotterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5645.2", 
          "name": [
            "University Hospital Rotterdam, Rotterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeekel", 
        "givenName": "H", 
        "id": "sg:person.0761546551.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761546551.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Rotterdam, Rotterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5645.2", 
          "name": [
            "University Hospital Rotterdam, Rotterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klinkenbijl", 
        "givenName": "J H G", 
        "id": "sg:person.012366472764.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012366472764.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bergen, Bergen, Norway", 
          "id": "http://www.grid.ac/institutes/grid.7914.b", 
          "name": [
            "University of Bergen, Bergen, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bakkevold", 
        "givenName": "K E", 
        "id": "sg:person.014400774424.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014400774424.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Teikyo University School of Medicine, Teikyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.264706.1", 
          "name": [
            "Teikyo University School of Medicine, Teikyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takada", 
        "givenName": "T", 
        "id": "sg:person.01145073410.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Teikyo University School of Medicine, Teikyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.264706.1", 
          "name": [
            "Teikyo University School of Medicine, Teikyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amano", 
        "givenName": "H", 
        "id": "sg:person.01315102374.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315102374.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "J P", 
        "id": "sg:person.012537142122.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/0-387-21600-6_20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016735956", 
          "https://doi.org/10.1007/0-387-21600-6_20"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1977.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027080276", 
          "https://doi.org/10.1038/bjc.1977.1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-04-05", 
    "datePublishedReg": "2005-04-05", 
    "description": "The aim of this study was to investigate the worldwide evidence of the roles of adjuvant chemoradiation and adjuvant chemotherapy on survival in potentially curative resected pancreatic cancer. Five randomised controlled trials of adjuvant treatment in patients with histologically proven pancreatic ductal adenocarcinoma were identified, of which the four most recent trials provided individual patient data (875 patients). This meta-analysis includes previously unpublished follow-up data on 261 patients. The pooled estimate of the hazard ratio (HR) indicated a 25% significant reduction in the risk of death with chemotherapy (HR=0.75, 95% confidence interval (CI): 0.64, 0.90, P-valuesstratified (Pstrat)=0.001) with median survival estimated at 19.0 (95% CI: 16.4, 21.1) months with chemotherapy and 13.5 (95% CI: 12.2, 15.8) without. The 2- and 5-year survival rates were estimated at 38 and 19%, respectively, with chemotherapy and 28 and 12% without. The pooled estimate of the HR indicated no significant difference in the risk of death with chemoradiation (HR=1.09, 95% CI: 0.89, 1.32, Pstrat=0.43) with median survivals estimated at 15.8 (95% CI: 13.9, 18.1) months with chemoradiation and 15.2 (95% CI: 13.1, 18.2) without. The 2- and 5-year survival rates were estimated at 30 and 12%, respectively, with chemoradiation and 34 and 17% without. Subgroup analyses estimated that chemoradiation was more effective and chemotherapy less effective in patients with positive resection margins. These results show that chemotherapy is effective adjuvant treatment in pancreatic cancer but not chemoradiation. Further studies with chemoradiation are warranted in patients with positive resection margins, as chemotherapy appeared relatively ineffective in this patient subgroup.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6602513", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "92"
      }
    ], 
    "keywords": [
      "positive resection margins", 
      "risk of death", 
      "hazard ratio", 
      "pancreatic cancer", 
      "adjuvant treatment", 
      "median survival", 
      "resection margins", 
      "survival rate", 
      "adjuvant therapy trials", 
      "effective adjuvant treatment", 
      "individual patient data", 
      "pancreatic ductal adenocarcinoma", 
      "adjuvant chemoradiation", 
      "adjuvant chemotherapy", 
      "patient subgroups", 
      "subgroup analysis", 
      "recent trials", 
      "ductal adenocarcinoma", 
      "chemoradiation", 
      "chemotherapy", 
      "therapy trials", 
      "patients", 
      "patient data", 
      "cancer", 
      "trials", 
      "significant differences", 
      "Further studies", 
      "survival", 
      "significant reduction", 
      "months", 
      "death", 
      "treatment", 
      "risk", 
      "adenocarcinoma", 
      "follow", 
      "subgroups", 
      "worldwide evidence", 
      "study", 
      "rate", 
      "aim", 
      "evidence", 
      "data", 
      "differences", 
      "margin", 
      "role", 
      "reduction", 
      "ratio", 
      "analysis", 
      "estimates", 
      "results"
    ], 
    "name": "Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer", 
    "pagination": "1372-1381", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015676534"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6602513"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15812554"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6602513", 
      "https://app.dimensions.ai/details/publication/pub.1015676534"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_411.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6602513"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602513'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602513'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602513'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602513'


 

This table displays all metadata directly associated to this object as RDF triples.

243 TRIPLES      21 PREDICATES      87 URIs      77 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6602513 schema:about N0759ba760ca5441598609e85c05ea0cb
2 N18497d48a1bf444eb00f3e764cbfbd7c
3 N1c550447a7c84fffa5950a5a407d2ce5
4 N74d1cf1b425b4714818b0a8a5f10213d
5 N809dea405981424f85e04419ff5e1196
6 N9768f56df7b848cc8c4379c1f82ba871
7 Nb6241f11d77c4297a6f55f04f12a9dac
8 Nbed102ffed41441db2e403ebc50a9db2
9 Ncb9f57628b3c4020bc4b2e04fed530b9
10 Nee566018a9a24ab3b4e6b1c06f252666
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author Ne89d124fc7af4efbb51e7299f7bd6659
14 schema:citation sg:pub.10.1007/0-387-21600-6_20
15 sg:pub.10.1038/bjc.1977.1
16 schema:datePublished 2005-04-05
17 schema:datePublishedReg 2005-04-05
18 schema:description The aim of this study was to investigate the worldwide evidence of the roles of adjuvant chemoradiation and adjuvant chemotherapy on survival in potentially curative resected pancreatic cancer. Five randomised controlled trials of adjuvant treatment in patients with histologically proven pancreatic ductal adenocarcinoma were identified, of which the four most recent trials provided individual patient data (875 patients). This meta-analysis includes previously unpublished follow-up data on 261 patients. The pooled estimate of the hazard ratio (HR) indicated a 25% significant reduction in the risk of death with chemotherapy (HR=0.75, 95% confidence interval (CI): 0.64, 0.90, P-valuesstratified (Pstrat)=0.001) with median survival estimated at 19.0 (95% CI: 16.4, 21.1) months with chemotherapy and 13.5 (95% CI: 12.2, 15.8) without. The 2- and 5-year survival rates were estimated at 38 and 19%, respectively, with chemotherapy and 28 and 12% without. The pooled estimate of the HR indicated no significant difference in the risk of death with chemoradiation (HR=1.09, 95% CI: 0.89, 1.32, Pstrat=0.43) with median survivals estimated at 15.8 (95% CI: 13.9, 18.1) months with chemoradiation and 15.2 (95% CI: 13.1, 18.2) without. The 2- and 5-year survival rates were estimated at 30 and 12%, respectively, with chemoradiation and 34 and 17% without. Subgroup analyses estimated that chemoradiation was more effective and chemotherapy less effective in patients with positive resection margins. These results show that chemotherapy is effective adjuvant treatment in pancreatic cancer but not chemoradiation. Further studies with chemoradiation are warranted in patients with positive resection margins, as chemotherapy appeared relatively ineffective in this patient subgroup.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N10778515ab1145ef997bed50bf350fef
22 N2d1b2f97efe4469dbfd5f424e695b0e8
23 sg:journal.1017082
24 schema:keywords Further studies
25 adenocarcinoma
26 adjuvant chemoradiation
27 adjuvant chemotherapy
28 adjuvant therapy trials
29 adjuvant treatment
30 aim
31 analysis
32 cancer
33 chemoradiation
34 chemotherapy
35 data
36 death
37 differences
38 ductal adenocarcinoma
39 effective adjuvant treatment
40 estimates
41 evidence
42 follow
43 hazard ratio
44 individual patient data
45 margin
46 median survival
47 months
48 pancreatic cancer
49 pancreatic ductal adenocarcinoma
50 patient data
51 patient subgroups
52 patients
53 positive resection margins
54 rate
55 ratio
56 recent trials
57 reduction
58 resection margins
59 results
60 risk
61 risk of death
62 role
63 significant differences
64 significant reduction
65 study
66 subgroup analysis
67 subgroups
68 survival
69 survival rate
70 therapy trials
71 treatment
72 trials
73 worldwide evidence
74 schema:name Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer
75 schema:pagination 1372-1381
76 schema:productId N81f7e44ece24415ea9169cde4e25bf41
77 N96205ed8a0d842aa86d56c96180f020f
78 Nfd7d9b88eb914425ab09a135af19e9d1
79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015676534
80 https://doi.org/10.1038/sj.bjc.6602513
81 schema:sdDatePublished 2022-10-01T06:33
82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
83 schema:sdPublisher Nc7235f9d39c34b0b867b889a90b69440
84 schema:url https://doi.org/10.1038/sj.bjc.6602513
85 sgo:license sg:explorer/license/
86 sgo:sdDataset articles
87 rdf:type schema:ScholarlyArticle
88 N0759ba760ca5441598609e85c05ea0cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Male
90 rdf:type schema:DefinedTerm
91 N0ac4566b9ce44137884fc4d5d1550c7c rdf:first sg:person.0761546551.82
92 rdf:rest N48eb446a7c0940988f6d506d227d3860
93 N10778515ab1145ef997bed50bf350fef schema:volumeNumber 92
94 rdf:type schema:PublicationVolume
95 N18497d48a1bf444eb00f3e764cbfbd7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Randomized Controlled Trials as Topic
97 rdf:type schema:DefinedTerm
98 N1c550447a7c84fffa5950a5a407d2ce5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Chemotherapy, Adjuvant
100 rdf:type schema:DefinedTerm
101 N2d1b2f97efe4469dbfd5f424e695b0e8 schema:issueNumber 8
102 rdf:type schema:PublicationIssue
103 N3be48292ea3e4c2080687d2d3eedb894 rdf:first sg:person.012537142122.12
104 rdf:rest rdf:nil
105 N48eb446a7c0940988f6d506d227d3860 rdf:first sg:person.012366472764.46
106 rdf:rest N7f34f8637de34133a63c101930c2b1de
107 N74d1cf1b425b4714818b0a8a5f10213d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Survival Analysis
109 rdf:type schema:DefinedTerm
110 N7f34f8637de34133a63c101930c2b1de rdf:first sg:person.014400774424.26
111 rdf:rest Neb632f0c56674ab39826ce507a890526
112 N809dea405981424f85e04419ff5e1196 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Radiotherapy, Adjuvant
114 rdf:type schema:DefinedTerm
115 N81f7e44ece24415ea9169cde4e25bf41 schema:name pubmed_id
116 schema:value 15812554
117 rdf:type schema:PropertyValue
118 N92fc4b2b0b80431a880086011fa5b8fb rdf:first sg:person.01345167253.21
119 rdf:rest N0ac4566b9ce44137884fc4d5d1550c7c
120 N96205ed8a0d842aa86d56c96180f020f schema:name doi
121 schema:value 10.1038/sj.bjc.6602513
122 rdf:type schema:PropertyValue
123 N9768f56df7b848cc8c4379c1f82ba871 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Female
125 rdf:type schema:DefinedTerm
126 Nb6241f11d77c4297a6f55f04f12a9dac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Humans
128 rdf:type schema:DefinedTerm
129 Nbed102ffed41441db2e403ebc50a9db2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Middle Aged
131 rdf:type schema:DefinedTerm
132 Nc7235f9d39c34b0b867b889a90b69440 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 Ncb9f57628b3c4020bc4b2e04fed530b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Pancreatic Neoplasms
136 rdf:type schema:DefinedTerm
137 Ne89d124fc7af4efbb51e7299f7bd6659 rdf:first sg:person.0750176774.36
138 rdf:rest Nfa55f7573a1c4d869218b0d1eaa8f0ce
139 Neb632f0c56674ab39826ce507a890526 rdf:first sg:person.01145073410.03
140 rdf:rest Nf69de00893bf4790b450dc78e172fc88
141 Nee566018a9a24ab3b4e6b1c06f252666 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Carcinoma, Pancreatic Ductal
143 rdf:type schema:DefinedTerm
144 Nf14c2a370e474e05a295ffa419c5d049 rdf:first sg:person.0733477707.10
145 rdf:rest N92fc4b2b0b80431a880086011fa5b8fb
146 Nf69de00893bf4790b450dc78e172fc88 rdf:first sg:person.01315102374.34
147 rdf:rest N3be48292ea3e4c2080687d2d3eedb894
148 Nfa55f7573a1c4d869218b0d1eaa8f0ce rdf:first sg:person.07610347412.52
149 rdf:rest Nf14c2a370e474e05a295ffa419c5d049
150 Nfd7d9b88eb914425ab09a135af19e9d1 schema:name dimensions_id
151 schema:value pub.1015676534
152 rdf:type schema:PropertyValue
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
157 schema:name Oncology and Carcinogenesis
158 rdf:type schema:DefinedTerm
159 sg:journal.1017082 schema:issn 0007-0920
160 1532-1827
161 schema:name British Journal of Cancer
162 schema:publisher Springer Nature
163 rdf:type schema:Periodical
164 sg:person.01145073410.03 schema:affiliation grid-institutes:grid.264706.1
165 schema:familyName Takada
166 schema:givenName T
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03
168 rdf:type schema:Person
169 sg:person.012366472764.46 schema:affiliation grid-institutes:grid.5645.2
170 schema:familyName Klinkenbijl
171 schema:givenName J H G
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012366472764.46
173 rdf:type schema:Person
174 sg:person.012537142122.12 schema:affiliation grid-institutes:grid.10025.36
175 schema:familyName Neoptolemos
176 schema:givenName J P
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12
178 rdf:type schema:Person
179 sg:person.01315102374.34 schema:affiliation grid-institutes:grid.264706.1
180 schema:familyName Amano
181 schema:givenName H
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315102374.34
183 rdf:type schema:Person
184 sg:person.01345167253.21 schema:affiliation grid-institutes:grid.5611.3
185 schema:familyName Bassi
186 schema:givenName C
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01345167253.21
188 rdf:type schema:Person
189 sg:person.014400774424.26 schema:affiliation grid-institutes:grid.7914.b
190 schema:familyName Bakkevold
191 schema:givenName K E
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014400774424.26
193 rdf:type schema:Person
194 sg:person.0733477707.10 schema:affiliation grid-institutes:grid.413412.1
195 schema:familyName Dervenis
196 schema:givenName C
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733477707.10
198 rdf:type schema:Person
199 sg:person.0750176774.36 schema:affiliation grid-institutes:grid.470294.c
200 schema:familyName Stocken
201 schema:givenName D D
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750176774.36
203 rdf:type schema:Person
204 sg:person.07610347412.52 schema:affiliation grid-institutes:grid.7700.0
205 schema:familyName Büchler
206 schema:givenName M W
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07610347412.52
208 rdf:type schema:Person
209 sg:person.0761546551.82 schema:affiliation grid-institutes:grid.5645.2
210 schema:familyName Jeekel
211 schema:givenName H
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761546551.82
213 rdf:type schema:Person
214 sg:pub.10.1007/0-387-21600-6_20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016735956
215 https://doi.org/10.1007/0-387-21600-6_20
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/bjc.1977.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027080276
218 https://doi.org/10.1038/bjc.1977.1
219 rdf:type schema:CreativeWork
220 grid-institutes:grid.10025.36 schema:alternateName University of Liverpool, Liverpool, UK
221 schema:name University of Liverpool, Liverpool, UK
222 rdf:type schema:Organization
223 grid-institutes:grid.264706.1 schema:alternateName Teikyo University School of Medicine, Teikyo, Japan
224 schema:name Teikyo University School of Medicine, Teikyo, Japan
225 rdf:type schema:Organization
226 grid-institutes:grid.413412.1 schema:alternateName Agia Olga Hospital, Athens, Greece
227 schema:name Agia Olga Hospital, Athens, Greece
228 rdf:type schema:Organization
229 grid-institutes:grid.470294.c schema:alternateName Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
230 schema:name Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
231 rdf:type schema:Organization
232 grid-institutes:grid.5611.3 schema:alternateName University of Verona, Verona, Italy
233 schema:name University of Verona, Verona, Italy
234 rdf:type schema:Organization
235 grid-institutes:grid.5645.2 schema:alternateName University Hospital Rotterdam, Rotterdam, The Netherlands
236 schema:name University Hospital Rotterdam, Rotterdam, The Netherlands
237 rdf:type schema:Organization
238 grid-institutes:grid.7700.0 schema:alternateName University of Heidelberg, Heidelberg, Germany
239 schema:name University of Heidelberg, Heidelberg, Germany
240 rdf:type schema:Organization
241 grid-institutes:grid.7914.b schema:alternateName University of Bergen, Bergen, Norway
242 schema:name University of Bergen, Bergen, Norway
243 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...